These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7798503)

  • 1. Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction.
    Merlini PA; Bauer KA; Oltrona L; Ardissino D; Spinola A; Cattaneo M; Broccolino M; Mannucci PM; Rosenberg RD
    J Am Coll Cardiol; 1995 Jan; 25(1):203-9. PubMed ID: 7798503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of fixed dose intravenous heparin to suppress increases in thrombin activity after coronary thrombolysis with streptokinase.
    Galvani M; Abendschein DR; Ferrini D; Ottani F; Rusticali F; Eisenberg PR
    J Am Coll Cardiol; 1994 Nov; 24(6):1445-52. PubMed ID: 7930274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
    Granger CB; Becker R; Tracy RP; Califf RM; Topol EJ; Pieper KS; Ross AM; Roth S; Lambrew C; Bovill EG
    J Am Coll Cardiol; 1998 Mar; 31(3):497-505. PubMed ID: 9502626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent thrombin generation during heparin therapy in patients with acute coronary syndromes.
    Merlini PA; Ardissino D; Bauer KA; Oltrona L; Pezzano A; Bottasso B; Rosenberg RD; Mannucci PM
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1325-30. PubMed ID: 9261263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction.
    Scharfstein JS; Abendschein DR; Eisenberg PR; George D; Cannon CP; Becker RC; Sobel B; Cupples LA; Braunwald E; Loscalzo J
    Am J Cardiol; 1996 Sep; 78(5):503-10. PubMed ID: 8806332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
    Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
    Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in thrombin generation after coronary thrombolysis with rt-PA or streptokinase with simultaneous heparin versus heparin alone.
    Réganon E; Ferrando F; Vila V; Villa P; Martínez-Sales V; Fayos L; Ruano M; Aznar J
    Haemostasis; 1998; 28(2):99-105. PubMed ID: 10087435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive coagulation induced by plasmin in patients treated with recombinant tissue-type plasminogen activator.
    Gram J; Munkvad S; Leebeek FW; Kluft C; Jespersen J
    Coron Artery Dis; 1993 Apr; 4(4):371-7. PubMed ID: 8261210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent generation of thrombin after acute myocardial infarction.
    Szczeklik A; Dropinski J; Radwan J; Krzanowski M
    Arterioscler Thromb; 1992 May; 12(5):548-53. PubMed ID: 1576116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. The European Cooperative Study Group.
    Rapold HJ; de Bono D; Arnold AE; Arnout J; De Cock F; Collen D; Verstraete M
    Circulation; 1992 Mar; 85(3):928-34. PubMed ID: 1537129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable angina.
    Mombelli G; Marchetti O; Haeberli A; Straub PW
    Am Heart J; 1998 Dec; 136(6):1106-13. PubMed ID: 9842027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy.
    Gulba DC; Barthels M; Westhoff-Bleck M; Jost S; Rafflenbeul W; Daniel WG; Hecker H; Lichtlen PR
    Circulation; 1991 Mar; 83(3):937-44. PubMed ID: 1900225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction.
    Nordt TK; Moser M; Kohler B; Ruef J; Peter K; Kübler W; Bode C
    Thromb Haemost; 1998 Dec; 80(6):881-6. PubMed ID: 9869154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes.
    Granger CB; Miller JM; Bovill EG; Gruber A; Tracy RP; Krucoff MW; Green C; Berrios E; Harrington RA; Ohman EM
    Circulation; 1995 Apr; 91(7):1929-35. PubMed ID: 7895349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers.
    Slaughter TF; LeBleu TH; Douglas JM; Leslie JB; Parker JK; Greenberg CS
    Anesthesiology; 1994 Mar; 80(3):520-6. PubMed ID: 8141448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
    Rao AK; Sun L; Chesebro JH; Fuster V; Harrington RA; Schwartz D; Gallo P; Matos D; Topol EJ
    Circulation; 1996 Nov; 94(10):2389-95. PubMed ID: 8921778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma resistance to activated protein C regulates the activation of coagulation induced by thrombolysis in patients with ischaemic heart disease.
    Pedersen OD; Gram J; Jespersen J
    Heart; 1997 Feb; 77(2):122-7. PubMed ID: 9068393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
    Gold HK; Torres FW; Garabedian HD; Werner W; Jang IK; Khan A; Hagstrom JN; Yasuda T; Leinbach RC; Newell JB
    J Am Coll Cardiol; 1993 Apr; 21(5):1039-47. PubMed ID: 8459055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the hemostatic mechanism during thrombolysis in patients with unstable angina pectoris.
    Merlini PA; Ardissino D; Bauer KA; Oltrona L; Spinola A; Diotallevi P; Rosenberg RD; Mannucci PM
    Blood; 1995 Nov; 86(9):3327-32. PubMed ID: 7579435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.